Ian Wilmut
Ian Wilmut was born in Edinburgh, Scotland, United Kingdom on July 7th, 1944 and is the Physicist. At the age of 79, Ian Wilmut biography, profession, age, height, weight, eye color, hair color, build, measurements, education, career, dating/affair, family, news updates, and networth are available.
At 79 years old, Ian Wilmut physical status not available right now. We will update Ian Wilmut's height, weight, eye color, hair color, build, and measurements.
Sir Ian Wilmut, OBE FMedSci FRSE (born 7 July 1944) is an English embryologist and Chair of the University of Edinburgh's Scottish Centre for Regenerative Medicine.
He is best known as the head of the research group that first cloned a mammal from an adult somatic cell, a Finnish Dorset lamb named Dolly.
In the 2008 New Year Honours, he was named OBE for services to embryogenesis and knighted.
Early life and education
Wilmut was born in Hampton Lucy, Warwickshire, England. Leonard Wilmut, Wilmut's father, suffered from diabetes for fifty years, eventually causing him to go blind. He attended the former Boys' High School in Scarborough, where his father was educated. Wilmut's childhood aspiration was to embark on a naval career, but he was unable to do so due to his colour blindness. Wilmut worked as a farmhand on weekends, causing him to study Agriculture at the University of Nottingham.
Wilmut spent eight weeks in Christopher Polge's laboratory, who is credited with inventing cryopreservation in 1949. Wilmut completed a Doctor of Philosophy degree at the University of Cambridge in 1971, where he earned a thesis on semen cryopreservation. He was a postgraduate student at Darwin College in Cambridge at the time.
Career and research
He has been involved in research focusing on gametes and embryogenesis since his PhD, as well as working at the Roslin Institute.
Wilmut was the founder of the research group that first cloned a mammal, a lamb named Dolly. Dolly died of a respiratory disease in 2003. However, Wilmut did not announce in 2008 that he would abandon somatic cell nuclear transfer, which Dolly had invented in favor of a new method developed by Shinya Yamanaka. In mice, this technique was used to derive pluripotent stem cells from differentiated adult skin cells, reducing the need to produce embryonic stem cells. According to Wilmut, this approach has a greater chance of treating degenerative diseases such as Parkinson's disease and stroke and heart attack patients.
Wilmut led the team that created Dolly but in 2006, Keith Campbell acknowledged that his colleague "6 percent" of the invention that made Dolly's birth possible, as well as the statement "I did not create Dolly" was incorrect. His supervisory position is in accordance with the position of principal investigator at Wilmut at the time of Dolly's inception.
Wilmut is an Emeritus Professor at the University of Edinburgh's Scottish Centre for Regenerative Medicine, and was named in the New Year Honours for contributions to science in 2008.
After Dolly: The Uses and Misuses of Human Cloning, co-authored with Roger Highfield in 2006.